Collection: THCP and CBDP Products - 300% More Potent!

Meet THCP the new Super THC 300% More Potent than Delta-9!

Hemp is the gift that keeps on giving. As research into hemp and exotic cannabinoids ramps up, the chemical complexity and potential of the plant are shown to be even more astounding than we may have thought. Introducing THCP (tetrahydrocannabiphorol) and CBDP (cannabidiphorol) - known to be up to 300% more potent than their standard counterparts.


Though these two phenomenally potent compounds were discovered decades ago – it was not until recently that the research into their structure and physiological effects received a second look. Note: the "p" suffix refers to their "phosphorylated" counterparts; in layman's terms, this means that they are molecules that contain an extra "PO4" molecule stuck to them.''

At present, almost 150 phytocannabinoids have been detected in the cannabis plant, although few have been isolated and studied. While this has been due in part to legal reasons—cannabis is still illegal at a federal level in the US, rendering research tricky—it’s also because most strains of cannabis are THC- or CBD-dominant, making the isolation and study of minor cannabinoids challenging. That said, heavy regulations in the hemp industry has create some crafty and disruptive innovators in the world of hemp extraction. It's not the well funded medicinal cannabis companies that are producing these astounding cannabinoids... it's the hemp extractors.

THCP and CBDP are two super potent phytocannabinoids

like so many others. While their uses still remain undiscovered, they are the only two cannabinoids that have been found to contain a second phosphoryl group. While it’s still unclear exactly how these extra PO4 groups influence the endocannabinoid system—and whether or not they act alone—there's no denying that THCP and CBDP are undoubtedly powerful compounds.

Whats Makes THCP more potent on the molecular level?

Both chemicals are chemically different from THC and CBD and their biological effects are also influenced in different ways. THCP binds to the CB1 receptor with higher affinity, while CBDP has a higher affinity for the CB2 receptor. In addition, THCP inhibits fat storage, whereas CBDP does not seem to have this effect at all. The biological effects of their interactions with the cannabinoid system are hard to predict, but it’s likely that they will be profound.

But what is it about these chemicals that makes them different? In fact, THCP and CBDP are both structurally similar. Both contain a phenol group covalently bonded to one olefinic carbonyl carbon in a pyran ring fused to an aromatic benzene ring. The presence of this phenol group is the basis for the difference in their cannabinoid activity. In THCP’s case, the phenol group is just one carbon away from being a THC molecule. 

The discovery that there are two more cannabinoids to add to the growing list is exciting, but the real significance may be yet to come. Since THCP and CBDP are both new molecules, they cannot be patented, which means they can’t be sold as pharmaceuticals. 

What are the implications for THCP and CBDP?

The implications of this find for cannabis research are vast; it has the potential to revolutionize studies into cannabinoids and their interactions with the cannabinoid receptors. However, it also has an important medical application. Cannabinol, which is isolated from the cannabis plant, has been widely used in medical practice since the 1990s. The role of cannabinol is well known and understood in both Western medicine and Eastern medicine. It can be used for detoxification, treating nausea and suppressing muscle spasms (among other conditions).

THC itself has also been isolated from cannabis before as have many of its analogues. Moreover, this research shows that there are many more cannabinoids that could potentially be produced and sold as pharmaceutical products. These molecules could be used for the treatment of a range of medical conditions both currently approved by the FDA and those that are not, but lack approved drugs.The possibilities are endless.

What else might these exotic cannabinoids do? At the very least, THCP and CBDP have the potential to be further researched into for their pharmacological effects and it would also mark a significant breakthrough in the use of medical marijuana. It’s also possible that these two new cannabinoids have some yet unknown medicinal properties.

And this is just the beginning. More research into phytocannabinoids could provide even more fascinating insights on our evolving understanding of the cannabinoids and their interactions with the body.

0 products

Sorry, there are no products in this collection